Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence

Abstract

Behavioral therapies, such as CM, can be targeted to address weaknesses of specific pharmacotherapies, such as noncompliance, and thus can play a substantial role in broadening the utility of available pharmacotherapies.